Romero A, Walker B, Krneta-Stankic V, Gerner-Mauro K, Youmans L, Miller R
Development. 2025; 152(3).
PMID: 39959988
PMC: 11883272.
DOI: 10.1242/dev.202820.
Grigoreva T, Kindt D, Sagaidak A, Novikova D, Tribulovich V
Cells. 2025; 14(3).
PMID: 39936962
PMC: 11817814.
DOI: 10.3390/cells14030170.
Bulbul M, Mermer A, Kolbasi B, Kocabas F, Kalender S, Kirectepe Aydin K
Pharmaceuticals (Basel). 2025; 17(12.
PMID: 39770404
PMC: 11678851.
DOI: 10.3390/ph17121562.
Uijttewaal E, Lee J, Sell A, Botay N, Vainorius G, Novatchkova M
Nat Biotechnol. 2024; .
PMID: 39681701
DOI: 10.1038/s41587-024-02512-9.
Hilai K, Grubich D, Akrawi M, Zhu H, Zaghloul R, Shi C
bioRxiv. 2024; .
PMID: 39005477
PMC: 11244934.
DOI: 10.1101/2024.06.27.601015.
MEF2D Functions as a Tumor Suppressor in Breast Cancer.
Wang X, Shen H, Chen Y, Zhang Y, Wang J, Liu S
Int J Mol Sci. 2024; 25(10).
PMID: 38791246
PMC: 11121549.
DOI: 10.3390/ijms25105207.
PI 3-Kinase and the Histone Methyl-Transferase KMT2D Collaborate to Induce Arp2/3-Dependent Migration of Mammary Epithelial Cells.
Rysenkova K, Gaboriaud J, Fokin A, Toubiana R, Bense A, Mirdass C
Cells. 2024; 13(10.
PMID: 38786098
PMC: 11119607.
DOI: 10.3390/cells13100876.
Morphological basis of the lung adenocarcinoma subtypes.
Zha L, Matsu-Ura T, Sluka J, Murakawa T, Tsuta K
iScience. 2024; 27(5):109742.
PMID: 38706836
PMC: 11066476.
DOI: 10.1016/j.isci.2024.109742.
An inexpensive "do-it-yourself" device for rapid generation of uniform tumor spheroids.
Namgung B, Dai H, Prathyushaa Vikraman P, Saha T, Sengupta S, Lin Jang H
Device. 2024; 2(3).
PMID: 38617078
PMC: 11008532.
DOI: 10.1016/j.device.2024.100255.
Inverted apicobasal polarity in health and disease.
Pasquier N, Jaulin F, Peglion F
J Cell Sci. 2024; 137(5).
PMID: 38465512
PMC: 10984280.
DOI: 10.1242/jcs.261659.
Oncogenic KRAS, Mucin 4, and Activin A-Mediated Fibroblast Activation Cooperate for PanIN Initiation.
Hu C, Huang C, Hsu M, Chien H, Wu P, Chen Y
Adv Sci (Weinh). 2023; 10(36):e2301240.
PMID: 37964407
PMC: 10754145.
DOI: 10.1002/advs.202301240.
Bladder cancer: therapeutic challenges and role of 3D cell culture systems in the screening of novel cancer therapeutics.
Farouk S, Khafaga A, Abdellatif A
Cancer Cell Int. 2023; 23(1):251.
PMID: 37880676
PMC: 10601189.
DOI: 10.1186/s12935-023-03069-4.
Three-dimensional growth sensitizes breast cancer cells to treatment with ferroptosis-promoting drugs.
Chipurupalli S, Jiang P, Liu X, Santos J, Marcato P, Rosen K
Cell Death Dis. 2023; 14(9):580.
PMID: 37658069
PMC: 10474142.
DOI: 10.1038/s41419-023-06106-2.
Three-Dimensional Cell Cultures: The Bridge between In Vitro and In Vivo Models.
Urzi O, Gasparro R, Costanzo E, De Luca A, Giavaresi G, Fontana S
Int J Mol Sci. 2023; 24(15).
PMID: 37569426
PMC: 10419178.
DOI: 10.3390/ijms241512046.
Septin 9 Orients the Apico-Basal Polarity Axis and Controls Plasticity Signals.
Cai T, Peng J, Omrane M, Benzoubir N, Samuel D, Gassama-Diagne A
Cells. 2023; 12(14).
PMID: 37508480
PMC: 10377970.
DOI: 10.3390/cells12141815.
Cas phosphorylation regulates focal adhesion assembly.
Kumar S, Stainer A, Dubrulle J, Simpkins C, Cooper J
Elife. 2023; 12.
PMID: 37489578
PMC: 10435235.
DOI: 10.7554/eLife.90234.
Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic Peptide.
Jannoo R, Walker W, Kanamarlapudi V
Cancers (Basel). 2023; 15(10).
PMID: 37345109
PMC: 10216279.
DOI: 10.3390/cancers15102772.
Riok1, A Novel Potential Target in MSI-High p53 Mutant Colorectal Cancer Cells.
Shechter S, Yaar Bar S, Khattib H, Gage M, Avni D
Molecules. 2023; 28(11).
PMID: 37298928
PMC: 10254355.
DOI: 10.3390/molecules28114452.
Small-molecule targeting of GPCR-independent noncanonical G-protein signaling in cancer.
Zhao J, DiGiacomo V, Ferreras-Gutierrez M, Dastjerdi S, de Opakua A, Park J
Proc Natl Acad Sci U S A. 2023; 120(18):e2213140120.
PMID: 37098067
PMC: 10160980.
DOI: 10.1073/pnas.2213140120.
Altered expression of anti-apoptotic protein Api5 affects breast tumorigenesis.
Kuttanamkuzhi A, Panda D, Malaviya R, Gaidhani G, Lahiri M
BMC Cancer. 2023; 23(1):374.
PMID: 37095445
PMC: 10127332.
DOI: 10.1186/s12885-023-10866-7.